---
title: "US FDA Breakthrough Device designation granted for Biotronik’s Freesolve BTK resorbable magnesium scaffold"
date: "2024-03-18T10:07:30.000Z"
publishedDate: "18 mars 2024"
summary: "Biotronik has been granted Breakthrough Device designation (BDD) from the US Food and Drug Administration (FDA) for the Freesolve below-the-knee (BTK) resorbable magnesium scaffold (RMS). The Freesolve BTK RMS is designed for individuals suffering from chronic limb-threatening ischaemia (CLTI)."
importance: ""
sourceUrl: "https://interventionalnews.com/us-fda-breakthrough-device-designation-granted-for-biotroniks-freesolve-btk-resorbable-magnesium-scaffold/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2024-03-18-us-fda-breakthrough-device-designation-granted-for-biotroniks-freesolve-btk-resorbable-magnesium-scaffold"
imageUrl: "https://interventionalnews.com/wp-content/uploads/sites/13/2024/03/Biotronik-Freesolve.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/us-fda-breakthrough-device-designation-granted-for-biotroniks-freesolve-btk-resorbable-magnesium-scaffold/"
---

![US FDA Breakthrough Device designation granted for Biotronik’s Freesolve BTK resorbable magnesium scaffold](https://interventionalnews.com/wp-content/uploads/sites/13/2024/03/Biotronik-Freesolve.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/us-fda-breakthrough-device-designation-granted-for-biotroniks-freesolve-btk-resorbable-magnesium-scaffold/*

## L’essentiel

Biotronik has been granted Breakthrough Device designation (BDD) from the US Food and Drug Administration (FDA) for the Freesolve below-the-knee (BTK) resorbable magnesium scaffold (RMS). The Freesolve BTK RMS is designed for individuals suffering from chronic limb-threatening ischaemia (CLTI).

## Lien source

https://interventionalnews.com/us-fda-breakthrough-device-designation-granted-for-biotroniks-freesolve-btk-resorbable-magnesium-scaffold/
